Drug intelligence / Profile preview

Equimatrix

Development stage: Unknown
Lead developer: NIBEC
Administration: Surgical Implant

Overview

Equimatrix is a bone graft material used in dental applications. It consists of granular spongy bone (cancellous bone granules) and is available in a variant called Equimatrix-Collagen which combines the bone material with Type I Collagen extracted and refined from porcine skin. It is primarily used for bone filling and restoration of bony defects in the mouth.

Brand names: Equimatrix
Other names: Equimatrix-Collagen

Beyond the preview

Go deeper on Equimatrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equimatrix.

Explore the full profile